Rochester Medical Corporation  

(Public, NASDAQ:ROCM)   Watch this stock  
Find more results for ROCM
Nov 13 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 9.17 - 20.13
Open     -
Vol / Avg. 0.00/61,131.00
Mkt cap 247.19M
P/E 58.11
Div/yield     -
EPS 0.34
Shares     -
Beta 1.05
Inst. own     -

Key stats and ratios

Q2 (Jun '13) 2012
Net profit margin 6.65% 3.32%
Operating margin 10.28% 5.21%
EBITD margin - 9.50%
Return on average assets 5.72% 2.46%
Return on average equity 6.32% 3.05%
Employees 344 -
CDP Score - -


1 Rochester Medical Dr NW
United States - Map
+1-507-5339600 (Phone)
+1-507-5339725 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Rochester Medical Corporation develops, manufactures and markets a range of polyvinyl chloride (PVC)-free and latex-free urinary continence and urine drainage care products for the extended care and acute care markets. The Company�s extended care products include a range of male external catheters (MECs) for managing male urinary incontinence and a range of intermittent catheters for managing both male and female urinary retention. Along with its silicone male external catheters, it also sells a range of latex male external catheters in the United Kingdom. Its Magic3 is a range of silicone intermittent catheters. Its extended care products also include the FemSoft Insert, a soft, liquid-filled, conformable urethral insert for managing female stress urinary incontinence in adult females. Effective November 14, 2013, CR Bard Inc acquired the entire share capital of Rochester Medical Corp.